Published in Health Expectations, Volume 12, Issue 4, December 1, 2009, pages 430-437.
At the time of publication, author Javier de la Fuente was not yet affiliated with Cal Poly.
The definitive version is available at https://doi.org/10.1111/j.1369-7625.2009.00534.x.
Research has documented the drastic reduction of unintentional poisonings of children since the introduction of child resistant (CR) packaging. However, studies also indicate that consumers report difficulty using CR packages, in part because tests which determine the ‘senior friendliness’ of CR designs that are used throughout the world disallow people with ‘overt or obvious’ disabilities from being test subjects. Our review of drug package usability suggests that the current tests of CR packaging can and should be revised to correct this problem. We use US legislation, regulation and data to exemplify these points, but the conclusions are applicable to all protocols that include the exclusionary provision.
2009 Authors and Blackwell Publishing